Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective

Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective

Recent developments in prostate-specific membrane antigen (PSMA) targeted diagnostic imaging and therapeutics (theranostics) promise to advance the management of primary, biochemically recurrent, and metastatic prostate cancer. In order to maximize the clinical impact of PSMA-targeted theranostics,...

Full description

Bibliographic Details
Main Authors: Thomas S. C. Ng, Xin Gao, Keyan Salari, Dimitar V. Zlatev, Pedram Heidari, Sophia C. Kamran
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
PSMA
PET
prostate cancer
radiation
theranostics
therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.722277/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.722277/full

Similar Items